We’re excited to share that the Spatial Technologies Unit (STU) is now officially recognized as a Dana Farber Harvard Cancer Center DF/HCC Core. This new designation means that DF/HCC members are eligible for internal pricing on STU services, supported in part by the Cancer Center Support Grant (CCSG).
STU provides access to state-of-the-art platforms for spatial transcriptomics, spatial proteomics, and high-resolution tissue imaging, making it possible to explore biological questions in the precise context of intact tissues. Whether you're mapping cellular microenvironments, studying tissue heterogeneity, or unraveling spatial gene expression, the Spatial Technologies Unit offers the technology and expertise to turn complex tissue data into actionable discovery.